Posted by Michael Wonder on 10 Apr 2017
D-day for women battling to get breast cancer drug Kadcyla
10 April 2017 - The drug Kadcyla is known to extend life by at least six months and in many case for years but it's not available on the NHS.
At 2 pm this afternoon, terminally ill Scots with HER2 positive breast cancer will either be thrown a lifeline or see it snatched away.
That’s when it will be announced whether Scotland’s NHS will prescribe cancer drug Kadcyla – known to extend the life of women with the metastasised form of the cancer by at least six months. In the US, some women are still alive on the drugs after five years or more.
The Record has campaigned for the drug to be given on the NHS to any woman who needs it.
